Status:
UNKNOWN
Effect of Perioperative Tranexamic Acid on Blood Loss During Management of Maxillofacial Trauma
Lead Sponsor:
College of Medical Sciences Teaching Hospital. Nepal
Conditions:
Blood Loss
Eligibility:
All Genders
16-65 years
Phase:
PHASE4
Brief Summary
This is a prospective, randomized, double-blind study investigating whether intravenous tranexamic acid has any effect on blood loss during maxillofacial trauma surgery, or the subsequent postoperativ...
Detailed Description
This is a prospective, randomized, double-blind pilot study investigating whether intravenous tranexamic acid has any effect on blood loss during maxillofacial trauma surgery, or the subsequent postop...
Eligibility Criteria
Inclusion
- Patients undergoing ORIF under GA for Maxillofacial fractures
- Patients between with ages of 16-65
- No cardiac comorbidities (hypertension, congenital heart malformation)
- No known coagulopathy
- No regular prescription medication altering normal blood coagulation (NSAIDs, other anticoagulants)
- ASA I and II patients
Exclusion
- Patients younger than 16 and older than 65
- Patients with known coagulopathy
- Patients with cardiac comorbidities
- Patients with a family history of bleeding disorders
- ASA III or higher
Key Trial Info
Start Date :
August 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04494126
Start Date
August 15 2021
End Date
December 15 2021
Last Update
August 3 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.